12 new conditions added to NMS from September 1, including atrial fibrillation and osteoporosis

The new medicine service (NMS) will be expanded from September 1 to include more therapeutic areas, the Pharmaceutical Services Negotiating Committee (PSNC) has announced.

The New Medicine Service will expand to cover more therapeutic areas
A catch-up NMS will also be temporarily available to those who could not access the service during COVID-19

Twelve additional conditions have been added to the service, PSNC announced today (August 23), as it published the outcome of the negotiations on year three of the community pharmacy contractual framework.

The conditions previously covered by the service specification remain in place, the negotiator clarified, and an updated list of medicines that are suitable for and covered by the service will be published “shortly” by the NHS Business Services Authority.

The extra conditions that will be covered by the NMS are:

  • Acute coronary syndrome
  • Atrial fibrillation
  • Coronary heart disease
  • Epilepsy
  • Glaucoma
  • Gout
  • Heart failure
  • Hypercholesterolaemia
  • Osteoporosis
  • Parkinson’s Disease
  • Stroke/transient ischemic attack
  • Urinary incontinence and retention.

Increase in cap on number of NMSs

Following the expansion of the service, the cap on the number of paid NMSs that contractors can complete will also increase from 0.5% to 1% “of monthly prescription volume” and “additional bandings will also be included”, PSNC added.

Meanwhile, the maximum remuneration for the service remains at £28 per completed NMS.

As C+D previously reported, the eligibility criteria for the NMS are being widened to allow carers of patients and the parents or guardians of children to benefit from the service where the person they look after is not able to provide consent themselves.

Catch-up NMS temporarily available

Patients who were prescribed a new medicine during the pandemic, but who could not receive NMS support at the time, will be able to access a catch-up NMS.

“To further support patients as part of the NHS COVID-19 recovery plan, the temporary introduction of catch-up NMS has been agreed,” PSNC said.

“Further details on the requirements will shortly be published in an updated service specification,” it added.

Sign in or register for free

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment0

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment3

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment3

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.